PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘Making Measurement Better’ How well things are going and how to make it better’ presented by Sean Manning, NHS England
2.5 Partnership working - Anne Forletta, Katherine HewittNHS England
Partnership working. Building partnerships with acute hospitals, voluntary and community services. Featuring examples from Birmingham and Coventry. Anne Forletta, My Healthcare Birmingham; Katherine Hewitt, Gateway Family Services, Birmingham.
Getting the balance right - Adult services role in improving transition Helena Gleeson
Leicester Royal Infirmary Representing RCP YAASG
NHS Improving Quality held an event in London on 31 July 2013 to progress the children and young people transition to adult services work with a focus on turning the rhetoric into practice entitled “Working to Define a Generic Service Specification for Transition”
This was a presentation done in a symposium on tele-psychiatry at Annual Conference of Indian Psychiatric Society South Zone, held at Chennai on 15 October 2016
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bu...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bundle by Dr Irene Carey, Susanna Shouls, Guy’s and St Thomas’ NHS Foundation Trust
The Better Care Fund is a pooled budget for health and social care spending in the city which is shared between NHS Sheffield Clinical Commissioning Group and Sheffield City Council.
This set of slides talks Health and Wellbeing Board members through plans for the Better Care Fund in 2016/17. The slides were presented at the Health and Wellbeing Board meeting on 31 March 2016.
The paper which supports these slides can be read and downloaded at: http://sheffielddemocracy.moderngov.co.uk/ieListDocuments.aspx?CId=366&MId=5996&Ver=4.
http://westwood.belmontvillage.com/events/event_details/ucla-lecture-alzheimers-and-dementia-care/
UCLA Lecture: Alzheimer’s and Dementia Care
Tuesday, March 24, 2015 | 2:00 – 3:00 p.m.
Belmont Village Senior Living
10475 Wilshire Blvd., Los Angeles, CA 90024
Michelle Panlilio, GNP
Dementia Care Manager
Please join us for an informative presentation by Alzheimer’s and Dementia expert Michelle Panlilio. Ms. Panlilio will discuss the UCLA Alzheimer’s and Dementia Care program and how it addresses the complex medical, behavioral, and social needs of those affected by memory loss and cognitive impairment. The following topics will be discussed:
• Program background and benefits
• Key findings to date
• Challenges and solutions
• The future of dementia care
Beverages will be served.
RSVP to the Concierge on or before Friday, March 20 at 310.475.7501.
Transition to adult services - Gill Levitt
NHS Improving Quality held an event in London on 31 July 2013 to progress the children and young people transition to adult services work with a focus on turning the rhetoric into practice entitled “Working to Define a Generic Service Specification for Transition”
Suomen Akatemian suunnittelu ja johdon tuki -yksikön johtaja Pentti Pulkkinen kertoo tutkimusrahoituspäätösten perusteista ja viestinnästä. Pentillä on takanaan pitkä ura Suomen Akatemiassa ja viimeiset vuodet hän on vastannut yksikkönsä toiminnan ja talouden suunnittelusta, strategisesta suunnittelusta ja tutkimusrahoituspäätösten perusteet -asiakirjan laadinnasta. Esitetty yliopistoviestinnän päivillä 4.6.2015
CSC - Tieteen tietotekniikan keskus Oy:n sovellusasiantuntija Atte Sillanpää kertoi yliopistoviestinnän päivillä 4.6.2015, kuinka CSC viestii tutkijoille palveluistaan. Miten urakehityksen eri vaiheessa olevat tutkijat voivat hyödyntää CSC:n palveluita?
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals PM Workshop 3: Vital Signs ‘Making Measurement Better’ How well things are going and how to make it better’ presented by Sean Manning, NHS England
2.5 Partnership working - Anne Forletta, Katherine HewittNHS England
Partnership working. Building partnerships with acute hospitals, voluntary and community services. Featuring examples from Birmingham and Coventry. Anne Forletta, My Healthcare Birmingham; Katherine Hewitt, Gateway Family Services, Birmingham.
Getting the balance right - Adult services role in improving transition Helena Gleeson
Leicester Royal Infirmary Representing RCP YAASG
NHS Improving Quality held an event in London on 31 July 2013 to progress the children and young people transition to adult services work with a focus on turning the rhetoric into practice entitled “Working to Define a Generic Service Specification for Transition”
This was a presentation done in a symposium on tele-psychiatry at Annual Conference of Indian Psychiatric Society South Zone, held at Chennai on 15 October 2016
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bu...NHS Improving Quality
Transforming End of Life Care in Acute Hospitals AM Workshop 2: AMBER Care Bundle by Dr Irene Carey, Susanna Shouls, Guy’s and St Thomas’ NHS Foundation Trust
The Better Care Fund is a pooled budget for health and social care spending in the city which is shared between NHS Sheffield Clinical Commissioning Group and Sheffield City Council.
This set of slides talks Health and Wellbeing Board members through plans for the Better Care Fund in 2016/17. The slides were presented at the Health and Wellbeing Board meeting on 31 March 2016.
The paper which supports these slides can be read and downloaded at: http://sheffielddemocracy.moderngov.co.uk/ieListDocuments.aspx?CId=366&MId=5996&Ver=4.
http://westwood.belmontvillage.com/events/event_details/ucla-lecture-alzheimers-and-dementia-care/
UCLA Lecture: Alzheimer’s and Dementia Care
Tuesday, March 24, 2015 | 2:00 – 3:00 p.m.
Belmont Village Senior Living
10475 Wilshire Blvd., Los Angeles, CA 90024
Michelle Panlilio, GNP
Dementia Care Manager
Please join us for an informative presentation by Alzheimer’s and Dementia expert Michelle Panlilio. Ms. Panlilio will discuss the UCLA Alzheimer’s and Dementia Care program and how it addresses the complex medical, behavioral, and social needs of those affected by memory loss and cognitive impairment. The following topics will be discussed:
• Program background and benefits
• Key findings to date
• Challenges and solutions
• The future of dementia care
Beverages will be served.
RSVP to the Concierge on or before Friday, March 20 at 310.475.7501.
Transition to adult services - Gill Levitt
NHS Improving Quality held an event in London on 31 July 2013 to progress the children and young people transition to adult services work with a focus on turning the rhetoric into practice entitled “Working to Define a Generic Service Specification for Transition”
Suomen Akatemian suunnittelu ja johdon tuki -yksikön johtaja Pentti Pulkkinen kertoo tutkimusrahoituspäätösten perusteista ja viestinnästä. Pentillä on takanaan pitkä ura Suomen Akatemiassa ja viimeiset vuodet hän on vastannut yksikkönsä toiminnan ja talouden suunnittelusta, strategisesta suunnittelusta ja tutkimusrahoituspäätösten perusteet -asiakirjan laadinnasta. Esitetty yliopistoviestinnän päivillä 4.6.2015
CSC - Tieteen tietotekniikan keskus Oy:n sovellusasiantuntija Atte Sillanpää kertoi yliopistoviestinnän päivillä 4.6.2015, kuinka CSC viestii tutkijoille palveluistaan. Miten urakehityksen eri vaiheessa olevat tutkijat voivat hyödyntää CSC:n palveluita?
Sublime Émilie - Insights into science and art through Kaija Saariaho’s opera.
Kaija Saariaho’s monodrama received its Finnish premiere April 2nd, 2015 at the Finnish National Opera. The title character Émilie du Châtelet (1706–1749) was a significant French Enlightenment mathematician, physicist and philosopher whose love of knowledge and science was equally matched by a passion for men, jewellery and gambling. Marquise du Châtelet is known as the first woman in the history of science to achieve significant results in mathematics and physics.
The scientific community and general audiences had a chance to learn about Émilie’s unique life and work on the eve of the premiere of the opera. A group of international researchers and artists who share an interest in her story came together for a series of lectures, discussions and music performances in Helsinki on 1–2 April 2015.
The event was prepared by the AvaraOpera collective, operating at University of the Arts Helsinki, and it is produced in collaboration with the Finnish National Opera. The event is jointly funded by University of the Arts and the Finnish Cultural Foundation.
http://bit.ly/sublimeemilie
Taideyliopiston sidosryhmälehti IssueX valottaa taidetta, yliopiston henkilöitä ja tekemistä laajemmassa yhteiskunnallisessa kontekstissa. IssueX on kaksivuotisen historiansa aikana ehtinyt niittää mainetta ja kunniaa niin kotimaassa kuin kansainvälisestikin. Millainen on lehden konsepti ja miten sitä tehdään? Aiheesta alustivat yliopistoviestinnän päivillä 3.6.2015 Art Director Ari Hirvonen Otavamediasta ja viestintä- ja markkinointipäällikkö Elisa Ylinen Taideyliopiston Sibelius-Akatemiasta.
Suomen Akatemian tiedottaja Leena Vähäkylä on toiminut Etsi Xpertti -palvelun vastaavana tiedottajana palvelun alusta alkaen eli vuodesta 2005. Leena valottaa yliopistoviestijöille palvelun tämän hetkisiä kuulumisia. Esitetty yliopistoviestinnän päivillä 4.6.2015
Sublime Émilie - Insights into science and art through Kaija Saariaho’s opera.
Kaija Saariaho’s monodrama received its Finnish premiere April 2nd, 2015 at the Finnish National Opera. The title character Émilie du Châtelet (1706–1749) was a significant French Enlightenment mathematician, physicist and philosopher whose love of knowledge and science was equally matched by a passion for men, jewellery and gambling. Marquise du Châtelet is known as the first woman in the history of science to achieve significant results in mathematics and physics.
The scientific community and general audiences had a chance to learn about Émilie’s unique life and work on the eve of the premiere of the opera. A group of international researchers and artists who share an interest in her story came together for a series of lectures, discussions and music performances in Helsinki on 1–2 April 2015.
The event was prepared by the AvaraOpera collective, operating at University of the Arts Helsinki, and it is produced in collaboration with the Finnish National Opera. The event is jointly funded by University of the Arts and the Finnish Cultural Foundation.
http://bit.ly/sublimeemilie
Miten puhua taiteellisesta tutkimuksesta tutkimuspiirien ulkopuolella? Taideyliopiston Kuvataideakatemian taiteellisen tutkimuksen professori Anita Seppä kertoi yliopistoviestinnän päivillä 3.6.2015, miten ja millaisin viestein Taideyliopiston tutkimuspaviljonki Venetsian taidebiennaalin yhteydessä kesällä 2015 jalkautui maailman tunnetuimpaan kansainvälisen taidetapahtumaan.
Taideyliopistossa järjestetään yli 800 yleisötapahtumaa vuosittain. Konsertteja, näyttelyitä, teatteri- ja tanssiesityksiä, luentoja ja seminaareja – sekä kaikkea niiden väliltä. Taiteellinen toiminta on Taideyliopiston koulutuksen ytimessä, ja se täyttää pitkälti niin opiskelijoiden kuin opettajienkin päiväohjelman. Taideyliopiston tapahtumaviestintää valottivat tiedottajat Jaana Forsström (Teatterikorkeakoulu) ja Henna Kontusalmi (Kuvataideakatemia) sekä markkinointisuunnittelija Johanna Laitinen (Sibelius-Akatemia) yliopistoviestinnän päivillä 3.6.2015
Helsingin apulaiskaupunginjohtaja Pekka Sauri on monikanavaisen ja reaaliaikaisen viestinnän edelläkävijä. Sauri reagoi ketterästi kaupunkilaisten toiveisiin muun muassa Twitterissä ja kertoo radiossa päätöksenteon taustoista. Minkälainen taustatyö ja johtamisfilosofia löytyy 13 000 viserryksen takaa? Esitetty yliopistoviestinnän päivillä 3.6.2015
Kolmen yliopiston yhdistyessä tarvittiin yhteinen julkaisualusta päivittäisviestinnälle, ulkoisen verkkoviestinnän kanavat sekä yhtenäiset some-käytännöt. Taideyliopiston tiedottaja Anna-Elina Matilainen ja Taideyliopiston Sibelius-Akatemian viestintäsuunnittelija Juha Sjöblom kertoivat intranetin ja www-sivujen suunnittelusta sekä some-kanavien suunnitelmallisesta käytöstä yliopistoviestinnän päivillä 3.6.2015.
Petri Koikkalainen on yhteiskuntatieteiden tohtori, akatemiatutkija Lapin yliopistossa. Hän tutkii akatemiatutkijakaudellaan kontekstin merkitystä politiikan teoriassa. Koikkalainen toimii Tieteentekijöiden liiton puheenjohtajana kaudella 2015–2016 ja pohtii puheenvuorossaan uusien rahoitusmuotojen vaikutusta tutkijan vapauteen. Esitetty yliopistoviestinnän päivillä 4.6.2015.
CSC - Tieteen tietotekniikan keskus Oy:n tiedottaja Heta Koski kertoo CSC:stä viestintämateriaalien sisällöntuottajana ja yhteistyökumppanina. Esitetty yliopistoviestinnän päivillä 4.6.2015
Anne Björklund työskentelee CSC - Tieteen tietotekniikan keskus Oy:n viestintäpäällikkönä ja kertoo maksuttomista palveluista, joita organisaatio tarjoaa korkeakouluille ja niiden henkilöstölle. Esitetty yliopistoviestinnän päivillä 4.6.2015.
Kun kolme perinteistä yliopistoa yhdistyi, tarvittiin uudenlainen identiteetti. Taideyliopiston vastaava viestintäpäällikkö Laura Manninen ja suunnittelutoimisto Bondin toimitusjohtaja Arttu Salovaara kertoivat yliopistoviestinnän päivillä 3.6.2015, miten syntyi palkintoja niittänyt ja kuohuntaakin herättänyt brändi. Mikä meni nappiin ja mitä tekisimme toisin?
A joint presentation on Real People, Real Data at the 2016 International Forum on Quality and Safety in Healthcare in Gothenburg, Sweden. Presented by Leanne Wells of the Consumers Health Forum of Australia; Sam Vaillancourt of St. Michael’s Hospital, Toronto, Canada, and; Dr Paresh Dawda of the Australian National University.
Acute hospitals end of life care best practiceNHSRobBenson
Delivering reliable best practice in an acute hospital setting for patients whose recovery is uncertain. Including details of the AMBER care bundle. Presentation from Anita Hayes and colleagues from England's National End of Life Care Programme as part of the Department of Health's QIPP end of life care workstream seminar series at Healthcare Innovation Expo 2011
News from the Coal Face: There’s light at the end of the tunnel. Presented by Dr Andrew Miller, General Practitioner, at HINZ 2014, 11 November 2014, 4.30pm, Marlborough Room
Healthcare -- putting prevention into practiceZafar Hasan
This slidedeck is submitted by Zafar Hasan because one of the trends in medicine for the last 20 years isa focus on prevention and this deck is an outstanding practice primer.
Risk profiling, multiple long term conditions & complex patients, integrated ...Dr Bruce Pollington
Dr Bruce Pollington web-ex presentation to LTC QIPP programme
Utilising risk profiling, and risk stratification to identify patients with multiple long term conditions requiring complex care through integrated care teams.
A Change in Behavior: Delirium, Terminal Restlessness, or Dementia, A Pragmat...VITAS Healthcare
This webinar leverages evidence-based data to help physicians and healthcare professionals differentiate delirium, terminal restlessness and dementia-related agitation in patients as they near the end of life.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
How should the primary care system respond to people with chronic disease and complex conditions?
1. How should the primary care system
respond to people with chronic
disease and complex conditions?
Leanne Wells
CEO, Consumers Health Forum of Australia
Chronic Disease & Mental Health Symposium
The Australian College of Mental Health Nurses in partnership
with the Australian Primary Health Care Nurses Association
and Australian Diabetes Educators Association
2. Overview
• Why primary health care matters?
• What is the patient experience?
• Current issues in primary health care?
• A better system?
3. Why primary health care matters?
• Growing chronic condition burden
• The setting where we prevent/treat most
• It’s efficient and accessible
• We can get good outcomes
• It’s the backbone of a strong health systems
4. Major chronic conditions of Australians 2014-15
3.5 million
1.6 million
203,400
2.6 million
1.2 million
1.2 million
370,1002.5 million
5. National Health Survey 2014-15
4 million
Australians
(17.5%)
reported having
a mental or
behavioural
condition
3.6 million
Australians
(15.8%) reported
co-existing long-
term mental and
behavioural and
physical health
conditions.
6. What is the impact?
Improving the way we
respond to co-morbid
physical and mental
health problems would
have a high impact in
terms of patient
experience and clinical
outcomes
WHY?
Because both of
these are
substantially
poorer relative to
those for people
with a single
condition
8. Primary care doctors from 10 countries:
is practice well prepared to manage patients with
complex needs?
COUNTRY Patients with… Patients needing…
Multiple
chronic
condit-
ions
Dem-
entia
Severe
mental
health
issues
Substance
use-related
issues
Long-
term
home
care
services
Social
services
Palliat-
ive care
AUS (n=747) 85% 46% 34% 19% 47% 41% 48%
CAN (n=2,284) 70 42 24 15 40 28 42
GER (n=559) 88 67 32 14 68 71 58
NET (n=618) 88 65 44 16 80 25 92
NZ (n=503) 81 41 24 20 54 48 62
NOR (n=864) 86 69 56 36 78 41 54
SWE (n=2,905) 66 57 14 6 51 45 25
SWIZ (n=1,065) 80 49 26 25 64 55 48
UK (n=1,001) 79 64 43 41 60 44 81
US (n=1,001) 76 47 16 16 46 32 41
Source: 2015 Commonwealth Fund international Health Policy Survey of primary Care Physicians
9. Primary care doctors from 10 countries:
practice capacity to provide enhanced access and care
management
C
o
u
n
t
r
y
Practice uses nurses/case
managers to monitor/ manage
care for chronic patients
Practice
staff…
Patients can….
Within
practice
Outside
practice
Make
frequent
home visits
Access
after
hours care
Email re
medical
concerns
View
records
online
AUS 75% 6% 25% 78% 30% 11%
CAN 43 23 19 48 15 7
GER 20 7 57 85 50 8
NET 78 14 88 94 57 13
NZ 83 7 20 92 53 24
NOR 32 37 20 80 32 3
SWE 75 13 24 75 61 20
SWIZ 8 52 43 69 80 11
UK 87 8 84 89 38 28
US 43 24 6 39 57 60
Source: 2015 Commonwealth Fund international Health Policy Survey of primary Care Physicians
10. 21% reported
WAITING LONGER THAN
ACCEPTABLE
23% from RURAL and
REMOTE areas
28% of patients felt their
GP DID NOT SPEND ENOUGH
TIME with them
1 in 8 reported issues
caused by
LACK OF COMMUNICATION
between professionals
28% of patients felt their
GP DID NOT LISTEN
carefully to them
WOMEN reported longer
wait times than men
23% v 18%
ABS Patient Experiences :
General Practice 2014-15
Survey
11. Chronic disease costs
1 in 3 have at least 1 chronic
condition
Medicare spending
INCREASING
Potentially
preventable
13. Primary Health Care Advisory Group
consultations
• A fragmented system and providers working in
isolation not as a team
• Uncoordinated care
• Difficulty finding services
• Service duplication, absent or delayed services
• Low uptake of eHealth and other health
technology
• Access problems due to cost, transport, language,
mobility and remoteness
• Feelings of disempowerment
14. Experience of the system
“I don’t have a huge support structure outside of hospital. I’ve
got my regular GP, because I have to have the same form filled
every two to three months saying I can’t return to work.
There’s a lot in the community if you can source it, but it’s
hard because most people don’t know what’s available ….. I
think what I’d tell people with a chronic condition is ….ask
questions and be proactive. They aren’t going to cure you, but
you they can help you get the most out of life”
“Michael”, type 2 diabetes
14
15. Impact of low health literacy
“As a patient with a lot of insight into my condition, the nurses
will listen to me”
“Katy”, dysautonomia, chronic fatigue,
asthma, chronic pain
“I can understand that living in the country that I’m not going
to have everything in one place. I’m not expecting the world.
But I think at least having visiting specialists would help – or
being told when they do have one – or central registries that
doctors could access. That would be helpful. There is so much
information out there, but nobody can get it”
“Eleanor”, intracranial hypertension
15
18. • Make life easier, more
convenient for ME
• Let ME take ownership
• Empower ME
• Include and respect ME
in the relationship
• Keep ME informed
• Enable transparent
access to MY
information
• Give ME the best care
you can
• Reduce MY costs
19. Accessible and Affordable
Care
Timely access to care based
on need
Well organised, without
organisational or systemic
barriers
Affordable for consumers
Equitable access
Coordinated and
Comprehensive Care
Linked care with good referral
and feedback
Integrated with supported
transitions across the system
Availability of a range of services
to multidisciplinary care
Complete personally controlled
health record
Appropriate Care
Meet the needs and preferences of
individuals
Evidence based with consumers
engaged in research
Treatment options, risks and
benefits identified
Safe and technically proficient with
risks minimised
Practitioner engages with
consumers, families and carers
to ensure understanding
Whole of person care
Take account of consumers
lives and personal values
Emotional
Physical
Cultural, spiritual and social
factors
Consider carers and support
Address risk factors and all
health problems
Principles of
Consumer –
Centred
Health care
Trust and Respect
Provider asks about and
understands concerns
Transparent
Accountable
Timely and effective
complaint resolution process
Shared responsibility and
decision making
Informed Decision Making
Access to right information at
right time
Information is clear and
understandable
Costs are clear
Personal choice and right to
refuse respected
Informed and timely consent
Consider carers and supporters
Planning and Governance
Partnership with consumers to
ensure sustainability
Consumers involved at all
levels of planning, system
design and service
development
Consumers involved in key
governance structures
20. Putting people in control of their own
health and care
• Engaging people in keeping healthy
• Shared decision making
• Supported self management
• Having a personal health or social care budget
• Involving families and carers
• Choosing a provider
• Taking part in research as part of your care and
treatment
• Evaluating services through feedback